A CASE-REPORT AND DESCRIPTION OF THE PHARMACOKINETIC BEHAVIOR OF INTRAPLEURALLY INSTILLED ETOPOSIDE

被引:24
作者
JONES, JM [1 ]
OLMAN, EA [1 ]
EGORIN, MJ [1 ]
AISNER, J [1 ]
机构
[1] UNIV MARYLAND,CTR CANC,DIV DEV THERAPEUT,BALTIMORE,MD 21201
关键词
D O I
10.1007/BF00434360
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:172 / 174
页数:3
相关论文
共 12 条
[1]  
ANDERSON CB, 1974, CANCER-AM CANCER SOC, V33, P916, DOI 10.1002/1097-0142(197404)33:4<916::AID-CNCR2820330405>3.0.CO
[2]  
2-U
[3]   PHARMACOLOGIC RATIONALE FOR REGIONAL DRUG DELIVERY [J].
COLLINS, JM .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :498-504
[4]  
DINCALCI M, 1982, CANCER CHEMOTH PHARM, V7, P141
[5]   INVITRO CYTO-TOXICITY OF VP-16 ON PRIMARY TUMOR AND METASTASIS OF LEWIS LUNG-CARCINOMA [J].
DINCALCI, M ;
ERBA, E ;
VAGHI, M ;
MORASCA, L .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (04) :377-380
[6]  
IZBICKI R, 1975, CANCER, V36, P1511, DOI 10.1002/1097-0142(197510)36:4<1511::AID-CNCR2820360445>3.0.CO
[7]  
2-7
[8]  
KAPLAN RS, 1984, 2ND P INT C MAL LYMP
[9]   MANAGEMENT OF PLEURAL EFFUSIONS IN BREAST-CANCER [J].
LEES, AW ;
HOY, W .
CHEST, 1979, 75 (01) :51-53
[10]  
LEFT A, 1978, ANN INTERN MED, V88, P532